Critical Reviews in Oncology / Hematology Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas Pier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, Richard Lutes, Andy Chi, Stefano Pileri Critical Reviews in Oncology / Hematology Volume 99, Pages 228-240 (March 2016) DOI: 10.1016/j.critrevonc.2015.12.018 Copyright © 2016 The Authors Terms and Conditions
Fig. 1 World Health Organization 2008 classification of mature T-cell lymphomas: cutaneous T-cell lymphomas (Swerdlow et al., 2008) +, positive; −, negative; ALK, anaplastic lymphoma kinase; EBV, Epstein-Barr virus; LPD, lymphoproliferative disorders; TCL, T-cell lymphoma; NK, natural killer; NOS, not otherwise specified. Critical Reviews in Oncology / Hematology 2016 99, 228-240DOI: (10.1016/j.critrevonc.2015.12.018) Copyright © 2016 The Authors Terms and Conditions